Dietary interventions, physical activity and pharmacological approaches that effectively increase adiponectin levels could potentially offer therapeutic benefits for conditions such as insulin resistance, type 2 diabetes, and chronic inflammation. This evidence concerns the gene ADIPOQ and type 2 diabetes mellitus.